2003
DOI: 10.1016/s0168-1605(03)00174-0
|View full text |Cite
|
Sign up to set email alerts
|

Enterococci in foods—a conundrum for food safety

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

13
327
1
57

Year Published

2007
2007
2017
2017

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 491 publications
(398 citation statements)
references
References 139 publications
13
327
1
57
Order By: Relevance
“…Franz et al (2003) showed that Enterococcus faecium, which is used in meat products as a probiotic, have anti-listerial properties. Pidcock et al (2002) demonstrated that L. acidophilus and bifidobacteria have inhibitory effects against L. monocytogenes and E. coli in Hungarian salami.…”
Section: Probioticsmentioning
confidence: 99%
“…Franz et al (2003) showed that Enterococcus faecium, which is used in meat products as a probiotic, have anti-listerial properties. Pidcock et al (2002) demonstrated that L. acidophilus and bifidobacteria have inhibitory effects against L. monocytogenes and E. coli in Hungarian salami.…”
Section: Probioticsmentioning
confidence: 99%
“…Cytolysins are responsible for lysing a broad range of eukaryotic and prokaryotic cells, while gelatinase (gelE) acts on collagenous material in tissues and facilitates in invasion. Sex pheromone facilitates the conjugation mediated uptake of antibiotic resistance and virulence traits [5,13].…”
Section: Virulence Of Enterococcimentioning
confidence: 99%
“…Virulence factors are mainly detected among clinical enterococcal isolates, although studies done on the prevalence of virulence traits among enterococcal strains isolated from food suggest that some strains harbour virulence traits as well [5]. In this regard Eaton and Gasson (2001) [13] showed that enterococcal virulence factors were present in clinical, food and starter culture isolates and the prevalence was higher among clinical strains, followed by food isolates; the lowest prevalence was observed for starter isolates.…”
Section: Virulence Of Enterococcimentioning
confidence: 99%
See 1 more Smart Citation
“…[3][4][5] Enterococci are usually not included in probiotic preparations, due to their association with abnormal physiological conditions, underlying disease and immunosuppression. 6 Despite the few negative reports, clinical trials have shown that Enterococcus faecium SF68 is effective in the prevention and treatment of diarrhea 7 and lowers the cholesterol levels in serum. 8 Enterococcus faecium CRL 183 lowered cholesterol levels by 43% in in vitro tests 9 and E. faecium Fargo 688!…”
Section: Introductionmentioning
confidence: 99%